Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation RNF168_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-01246 | RNF168 | down-regulates | FGF9 | represses | R-1768 | 4 | 1 | Drugs (1) |
CMF-01248 | RNF168 | down-regulates | HOXB8 | represses | R-1699 | 7 | 2 | Drugs (28) Regulator Drugs (0)Regulon Drugs (28)RUXOLITINIB, PACRITINIB, LONAFARNIB, IZENCITINIB, TOFACITINIB, GANDOTINIB, RUXOLITINIB PHOSPHATE, PEFICITINIB, FORIGERIMOD, TIPIFARNIB, LESTAURTINIB, AC-430, MOMELOTINIB, NS-018, BARICITINIB, BMS-911543, UPADACITINIB, FEDRATINIB HYDROCHLORIDE, ZOTIRACICLIB, TOFACITINIB CITRATE, FORIGERIMOD ACETATE, GUSACITINIB, XL-019, AZD-1480, DELGOCITINIB, OCRIPLASMIN, AT-9283, FEDRATINIB |
CMF-01253 | RNF168 | up-regulates | RELA | activates | R-3149 | 3 | 1 | Drugs (2) |
CMF-01256 | RNF168 | down-regulates | FOXA2 | represses | R-2029 | 11 | 1 | Drugs (1) |
CMF-33906 | RNF168 | down-regulates | hsa-mir-328 | represses | R-2945 | 27 | 1 | Drugs (7) Regulator Drugs (0)Regulon Drugs (7)BINTRAFUSP ALFA, TRABEDERSEN, LUSPATERCEPT, SULTHIAME, FRESOLIMUMAB, TOSEDOSTAT, BIVATUZUMAB |
CMF-33907 | RNF168 | down-regulates | hsa-mir-30d | represses | R-2224 | 29 | 4 | Drugs (1) |
CMF-33908 | RNF168 | down-regulates | hsa-mir-30d | represses | R-2446 | 29 | 4 | Drugs (1) |
CMF-33909 | RNF168 | down-regulates | hsa-mir-30d | represses | R-1459 | 29 | 4 | Drugs (1) |
CMF-33910 | RNF168 | down-regulates | hsa-mir-30d | represses | R-1820 | 29 | 4 | Drugs (1) |